These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17219251)

  • 21. Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer.
    Takao M; Okamoto A; Nikaido T; Urashima M; Takakura S; Saito M; Saito M; Okamoto S; Takikawa O; Sasaki H; Yasuda M; Ochiai K; Tanaka T
    Oncol Rep; 2007 Jun; 17(6):1333-9. PubMed ID: 17487387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
    Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
    Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
    Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
    Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection.
    Yang GH; Fan J; Xu Y; Qiu SJ; Yang XR; Shi GM; Wu B; Dai Z; Liu YK; Tang ZY; Zhou J
    Oncologist; 2008 Nov; 13(11):1155-65. PubMed ID: 18997126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
    Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
    Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor.
    Hsu KH; Tsai HW; Lin PW; Hsu YS; Shan YS; Lu PJ
    Ann Surg Oncol; 2010 Aug; 17(8):2199-212. PubMed ID: 20146103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of iNOS in epithelial ovarian cancer.
    Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
    Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical prognostic factors for ovarian metastasis in women with gastric cancer.
    Yook JH; Oh ST; Kim BS
    Hepatogastroenterology; 2007; 54(75):955-9. PubMed ID: 17591102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
    Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
    Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
    Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study.
    Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC
    Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
    Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.